|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Loss | |||||
| Adjustment To Reconcile Net Loss to Net Cash Used In Operating Activities | |||||
| Due from Tebex | |||||
| Depreciation and Amortization | |||||
| Stock based compensation | |||||
| Impairment Cost | |||||
| Impairment Cost of Intangible Assets | |||||
| Write-off of liabilities past statute of limitations | |||||
| Changes in operating assets and liabilities | |||||
| Prepaid expenses | |||||
| Accounts Payable - Related Party | |||||
| Accounts Payable and accrued expenses | |||||
| Net Cash Provided By (Used in) Operating Activities | |||||
| Investing Activities | |||||
| Purchase of Digital Assets | |||||
| Selling Digital Assets | |||||
| Reclass Digital Assets | |||||
| Write-off | |||||
| Net Reconcilation of Non-Cash Financing and Investment Activites | |||||
| Purchase of Intangible Assets | |||||
| Net Cash Provided By (Used in) Investing Activities | |||||
| Common Stock: Conversion | |||||
| Net Cash Provided By (Used In) Financing Activities | |||||
| Change in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents, Beginning Of Year | |||||
| Cash and Cash Equivalents, End Of Year | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
Loading...